- Report Details: This report is based on analysis of financial balance sheet and income statement data for the period of 2000-2012, quantitative survey research results, and interactions with pharmaceutical clients in supply chain strategy engagements.
- Objective: To use financial balance sheet and income statement data coupled with recent research to better understand the state of pharmaceutical supply chains.
- Hypothesis: The pharmaceutical industry has struggled as a result of the Great Recession, complexities inherited as a result of M&A activity, and confronts looming Patent Cliffs requiring it to adapt and adopt new techniques to prioritize supply chain excellence and regain stability.
Supply Chain Metrics That Matter: A Focus on the Pharmaceutical Industry – 3 DEC 2012 from Lora Cecere
- Full Report (PDF) – click here
View more documents from Lora Cecere, Abby Mayer and Supply Chain Insights